Transcriptome and histological analysis under the CJL condition revealed activation of the TWEAK/Fn14 signaling pathway and reduced myofiber cross-sectional area (CSA), suggesting that this mouse model recapitulates the pathophysiology of sarcopenia. The gene discussed is TNFRSF12A; the disease is sarcopenia.